These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23817076)

  • 1. Image-guided drug delivery to the brain using nanotechnology.
    Ding H; Wu F; Nair MP
    Drug Discov Today; 2013 Nov; 18(21-22):1074-80. PubMed ID: 23817076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image guided biodistribution and pharmacokinetic studies of theranostics.
    Ding H; Wu F
    Theranostics; 2012; 2(11):1040-53. PubMed ID: 23227121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
    Dilnawaz F; Sahoo SK
    Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnologies: a strategy to overcome blood-brain barrier.
    De Rosa G; Salzano G; Caraglia M; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
    Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
    Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.
    Silva GA
    BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S4. PubMed ID: 19091001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical methods for brain targeted delivery system in vivo: perspectives on imaging modalities and microdialysis.
    Zhang X; Liu L; Zhang X; Ma K; Rao Y; Zhao Q; Li F
    J Pharm Biomed Anal; 2012 Feb; 59():1-12. PubMed ID: 22088476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
    Muldoon LL; Tratnyek PG; Jacobs PM; Doolittle ND; Christoforidis GA; Frank JA; Lindau M; Lockman PR; Manninger SP; Qiang Y; Spence AM; Stupp SI; Zhang M; Neuwelt EA
    AJNR Am J Neuroradiol; 2006 Mar; 27(3):715-21. PubMed ID: 16552023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in nanomedicines for diagnosis of central nervous system disorders.
    Zhang X; Zhou J; Gu Z; Zhang H; Gong Q; Luo K
    Biomaterials; 2021 Feb; 269():120492. PubMed ID: 33153757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier.
    Tan Q; Zhao S; Xu T; Wang Q; Lan M; Yan L; Chen X
    J Mater Chem B; 2022 Nov; 10(45):9314-9333. PubMed ID: 36349976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.
    Gao X; Yue Q; Liu Y; Fan D; Fan K; Li S; Qian J; Han L; Fang F; Xu F; Geng D; Chen L; Zhou X; Mao Y; Li C
    Theranostics; 2018; 8(11):3126-3137. PubMed ID: 29896307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
    Hassanzadeh P; Atyabi F; Dinarvand R
    Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.